Likun Cui

1.2k total citations · 2 hit papers
22 papers, 886 citations indexed

About

Likun Cui is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Likun Cui has authored 22 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Likun Cui's work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and interferon and immune responses (2 papers). Likun Cui is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers) and interferon and immune responses (2 papers). Likun Cui collaborates with scholars based in China, United States and Canada. Likun Cui's co-authors include Stephen Whitelam, Hong‐Gang Liao, Haimei Zheng, Sheng Xu, Jie Chen, Shuai Zhang, Chaoting Zhang, Nan Wu, Yanshuo Han and Zheming Lu and has published in prestigious journals such as Science, ACS Nano and Chemical Engineering Journal.

In The Last Decade

Likun Cui

19 papers receiving 879 citations

Hit Papers

Real-Time Imaging of Pt 3 Fe Nanorod Growth in Solution 2012 2026 2016 2021 2012 2024 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Likun Cui China 9 389 177 140 139 126 22 886
Nathalie Claes Belgium 16 579 1.5× 241 1.4× 204 1.5× 123 0.9× 265 2.1× 33 1.1k
Alexander Skorikov Belgium 12 157 0.4× 50 0.3× 64 0.5× 29 0.2× 199 1.6× 18 420
Chi-Jen Liu Switzerland 11 227 0.6× 67 0.4× 64 0.5× 107 0.8× 255 2.0× 11 666
Matthias Friedrich Germany 14 837 2.2× 363 2.1× 50 0.4× 143 1.0× 161 1.3× 18 1.2k
Nina Kostevšek Slovenia 15 178 0.5× 65 0.4× 111 0.8× 47 0.3× 220 1.7× 32 506
Cédric Louis France 16 736 1.9× 51 0.3× 110 0.8× 197 1.4× 284 2.3× 36 1.2k
Hsiang‐Hsin Chen Taiwan 15 212 0.5× 35 0.2× 116 0.8× 40 0.3× 291 2.3× 23 723
Arnaud Glaria France 13 310 0.8× 79 0.4× 77 0.6× 87 0.6× 216 1.7× 14 698
Changqian Cao China 13 472 1.2× 108 0.6× 454 3.2× 185 1.3× 328 2.6× 28 1.2k
Helena Gavilán Spain 19 399 1.0× 257 1.5× 192 1.4× 77 0.6× 872 6.9× 27 1.3k

Countries citing papers authored by Likun Cui

Since Specialization
Citations

This map shows the geographic impact of Likun Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Likun Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Likun Cui more than expected).

Fields of papers citing papers by Likun Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Likun Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Likun Cui. The network helps show where Likun Cui may publish in the future.

Co-authorship network of co-authors of Likun Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Likun Cui. A scholar is included among the top collaborators of Likun Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Likun Cui. Likun Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yang, Likun Cui, Jianwei Dong, et al.. (2025). Potential of bone marrow mesenchymal stem cells in iodine-induced autoimmune thyroiditis therapy. European Thyroid Journal. 14(3).
2.
Yu, Guanyu, Likun Cui, Mengqi Song, et al.. (2024). Siglec‐G Suppresses CD8+ T Cells Responses through Metabolic Rewiring and Can be Targeted to Enhance Tumor Immunotherapy. Advanced Science. 11(45). e2403438–e2403438. 6 indexed citations
3.
Fu, Ping, Miao Wang, Likun Cui, et al.. (2024). DMT1 ubiquitination by Nedd4 protects against ferroptosis after intracerebral hemorrhage. CNS Neuroscience & Therapeutics. 30(4). e14685–e14685. 10 indexed citations
4.
Liu, Xiang, et al.. (2024). The deubiquitinase BAP1 and E3 ligase UBE3C sequentially target IRF3 to activate and resolve the antiviral innate immune response. Cell Reports. 43(8). 114608–114608. 3 indexed citations
7.
Chen, Jie, et al.. (2024). Amino acid metabolism in tumor biology and therapy. Cell Death and Disease. 15(1). 42–42. 97 indexed citations breakdown →
8.
Cheng, Xueqing, Chuanshi He, Juan Li, et al.. (2024). A Tumor-Homing Nanoframework for Synergistic Microwave Tumor Ablation and Provoking Strong Anticancer Immunity Against Metastasis. ACS Nano. 18(42). 29121–29139. 8 indexed citations
9.
Cui, Likun, et al.. (2023). Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker. Genes. 14(10). 1961–1961. 3 indexed citations
10.
Zhang, Shenyang, Zuohui Zhang, Jie Zu, et al.. (2023). Increased plasma levels of circPTP4A2 and circTLK2 are associated with stroke injury. Annals of Clinical and Translational Neurology. 10(8). 1481–1492. 7 indexed citations
11.
Shen, Luyan, Chaoting Zhang, Likun Cui, et al.. (2022). Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity. Cancer Letters. 538. 215710–215710. 50 indexed citations
12.
Cui, Likun, Chaoting Zhang, Huirong Ding, et al.. (2022). Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto’s Thyroiditis. Frontiers in Immunology. 13. 821601–821601. 4 indexed citations
13.
Cui, Likun, et al.. (2022). Clinical outcomes of multifocal papillary thyroid cancer: A systematic review and meta‐analysis. Laryngoscope Investigative Otolaryngology. 7(4). 1224–1234. 14 indexed citations
14.
Su, Peng, et al.. (2022). Quasi-Static Mechanical Properties and Continuum Constitutive Model of the Thyroid Gland. Journal of Functional Biomaterials. 13(4). 283–283. 2 indexed citations
15.
Cui, Likun, et al.. (2019). Calycosin Ameliorates Inflammatory Paw Edema in Mice via Inhibiting NF-κB Activation. International Journal of Pharmacology. 15(6). 745–751. 3 indexed citations
16.
Luo, Jing, et al.. (2019). Fmo1 Gene Expression Independently Predicts Favorable Recurrence-Free Survival of Classical Papillary Thyroid Cancer. Future Oncology. 15(12). 1303–1311. 10 indexed citations
17.
Cui, Likun, et al.. (2019). MHC Class I Molecules Exacerbate Viral Infection by Disrupting Type I Interferon Signaling. Journal of Immunology Research. 2019. 1–9. 19 indexed citations
18.
Ding, Changjun, Huanxin Yang, Jiandong Wang, et al.. (2018). Corrosion and Protection of Materials for Grounding Grid. Corrosion Science and Protetion Technology. 31(1). 109–113. 2 indexed citations
19.
Cui, Likun, Yanshuo Han, Shuai Zhang, Xun Liu, & Jian Zhang. (2018). Safety of Stenting and Endarterectomy for Asymptomatic Carotid Artery Stenosis: A Meta-Analysis of Randomised Controlled Trials. Journal of Vascular Surgery. 67(6). 1938–1938. 1 indexed citations
20.
Cui, Likun, Yanshuo Han, Shuai Zhang, Xun Liu, & Jian Zhang. (2018). Safety of Stenting and Endarterectomy for Asymptomatic Carotid Artery Stenosis: A Meta-Analysis of Randomised Controlled Trials. European Journal of Vascular and Endovascular Surgery. 55(5). 614–624. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026